L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
Efficacy and tolerance of a keratolytic and hydrating shampoo in subjects with mild-to-moderate Scalp Psoriasis: results from a double-blind, randomized, vehicle-controlled study conducted under real-life conditions
Philippe Massiot, Pedro Contreiras Pinto, Virginie Rasmont, Bianca Maria Piraccini, Lidia Rudnicka, Daniel Fernandes Melo, Sergio Vano-Galvan, Wen-Yu Wu, Stephanie Leclerc-Mercier, Delphine Kerob
- 10min (reading time)
- Mar. 2023
- Supported by
INTRODUCTION
Psoriasis is a chronic, inflammatory skin disease that affects 2% of the global population.1
Scalp psoriasis is estimated to affect up to 80% of patients with psoriasis and can lead to a significant burden and impairment of quality of life (QoL).2-4
Due to its chronicity and the poor cosmeticity of topical treatments, compliance to local treatments is a frequent issue in psoriasis.
A keratolytic and hydrating shampoo containing 2% salicylic acid, 5% urea and 1% glycerin acting specifically on psoriasis symptoms has been developed for psoriasis prone scalp.